Written and maintained by CASRAI Editorial Board
Last updated
Patient-Reported Outcome Measures (PROMs) are standardized, psychometrically validated questionnaires and scoring instruments completed directly by patients to quantify their perception of their own health status, symptom burden, functional ability, and health-related quality of life (HRQoL) without interpretation or amendment by a clinician or third party. In clinical trials, regulatory drug and device submissions, and hospital quality reporting, PROMs serve as the measurement instruments used to capture a Patient-Reported Outcome (PRO)—one of the four core Clinical Outcome Assessment (COA) categories defined by the U.S. Food and Drug Administration (FDA) and National Institutes of Health (NIH) BEST (Biomarkers, EndpointS, and other Tools) framework.
What Are PROMs and What Is a Patient-Reported Outcome?
In health outcomes research and regulatory science, four closely related terms—PRO, PROM, PRO-PM, and PREM—have distinct operational definitions established by the FDA (Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims) and the Centers for Medicare & Medicaid Services (CMS) Measures Management System:
- Patient-Reported Outcome (PRO): Any report of the status of a patient’s health condition, health behavior, or experience with treatment that comes directly from the patient, without amendment or interpretation of the patient’s response by a clinician or anyone else. Examples of PRO concepts include pain intensity, fatigue severity, nausea frequency, physical mobility, and depressive symptoms.
- Patient-Reported Outcome Measure (PROM): The specific, validated instrument, questionnaire, item bank, or rating scale—together with its administration instructions, recall period, and scoring algorithm—used to measure a PRO concept. For example, while knee pain and function is the PRO concept, the KOOS Jr. (Knee Injury and Osteoarthritis Outcome Score for Joint Replacement) is the PROM.
- Patient-Reported Outcome-Based Performance Measure (PRO-PM): A healthcare quality performance measure built by aggregating patient-level PROM scores across a defined clinical population denominator (with specified exclusions and risk-adjustment variables) to evaluate facility or clinician quality—such as the mandatory CMS Hospital Inpatient Quality Reporting (IQR) Total Hip and Total Knee Arthroplasty (THA/TKA) PRO-PM. See Patient-Reported Outcome Measures (PROMs) in Hospital Quality Reporting for CMS reporting specifications.
- Patient-Reported Experience Measure (PREM): A survey instrument (such as the AHRQ/CMS Hospital Consumer Assessment of Healthcare Providers and Systems, or HCAHPS) that captures the patient’s perception of the process of healthcare delivery—such as nurse/physician communication, care coordination, and discharge instructions—rather than the clinical or functional health outcome resulting from treatment.
PROs Within the FDA-NIH BEST Clinical Outcome Assessment (COA) Taxonomy
Under the FDA-NIH BEST Resource and FDA Patient-Focused Drug Development (PFDD) guidance series, Clinical Outcome Assessments (COAs) are divided into four categories depending on who reports the assessment and how it is elicited:
| COA Category | Reporter & Assessment Method | When Used in Clinical Trials & Care | Representative Validated Instruments |
|---|---|---|---|
| Patient-Reported Outcome (PRO) | Reported directly by the patient without clinician interpretation | Symptoms only the patient can know (pain, fatigue, itch, anxiety) and self-perceived daily functioning or HRQoL | NIH PROMIS item banks, PHQ-9, GAD-7, EORTC QLQ-C30, SF-36, EQ-5D-5L, HOOS Jr., KOOS Jr., ODI |
| Clinician-Reported Outcome (ClinRO) | Reported by a trained healthcare professional after clinical observation or examination of the patient | Clinical signs, observable behaviors, or disease activity requiring professional medical judgment | NIH Stroke Scale (NIHSS), UPDRS motor examination, Psoriasis Area and Severity Index (PASI) |
| Observer-Reported Outcome (ObsRO) | Reported by a non-clinician observer (such as a parent, spouse, or caregiver) who regularly observes the patient in daily life | Pediatric, cognitive-impairment, or critical-care populations unable to self-report observable behaviors (e.g., vomiting episodes, crying, seizure frequency) | FLACC Behavioral Pain Scale, caregiver daily seizure or emesis diaries |
| Performance Outcome (PerfO) | Measured by having the patient perform a standardized, defined task according to strict instructions | Objective physical, cognitive, or sensory capacity quantified by time, distance, or accuracy | 6-Minute Walk Test (6MWT), Timed Up and Go (TUG) test, 9-Hole Peg Test, digit symbol substitution test |
A critical regulatory rule in the FDA PRO Guidance is that an observer or clinician cannot report a PRO on behalf of a patient: if a patient cannot self-report, the assessment must measure only observable signs and behaviors and is classified as an ObsRO or ClinRO rather than a proxy PRO.
Types of Patient-Reported Outcome Measures: Generic vs. Condition-Specific vs. Item Banks
Researchers and health systems selecting an instrument (see Choosing and Validating a Patient-Reported Outcome Measure) classify PROMs into three structural architectures:
1. Generic PROMs and Health Utility Instruments
Generic PROMs evaluate broad physical, mental, and social health domains applicable across diverse diseases and healthy reference populations. Because they are not restricted to a single pathology, generic PROMs enable cross-disease comparisons and cost-utility health economic modeling:
- Health Status Profile Instruments: Measure multiple HRQoL domains separately (such as the 36-Item Short Form Survey [SF-36], VR-12, and PROMIS Global-10).
- Preference-Based Utility Instruments: Generate a single cardinal health-state utility index anchored at
0.0(death) and1.0(full health) used to calculate Quality-Adjusted Life Years (QALYs) in health technology assessment (such as the EuroQol EQ-5D-5L and the Health Utilities Index Mark 3 [HUI3]).
2. Disease-Specific and Condition-Specific PROMs
Condition-specific PROMs focus on symptoms, side effects, and functional limitations characteristic of a particular diagnosis, anatomical region, or treatment modality, offering higher responsiveness (sensitivity to clinical change) in interventional trials:
- Oncology: The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), Functional Assessment of Cancer Therapy (FACT-G), and the NCI PRO-CTCAE (Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events) for symptomatic treatment toxicities.
- Orthopedics and Musculoskeletal Care: HOOS Jr. (hip), KOOS Jr. (knee), Oswestry Disability Index (ODI, lumbar spine), and QuickDASH (upper extremity).
- Behavioral Health and Psychiatry: Patient Health Questionnaire-9 (PHQ-9, depressive symptom severity) and Generalized Anxiety Disorder-7 (GAD-7).
3. IRT-Calibrated Item Banks and Computerized Adaptive Testing (NIH PROMIS)
Developed under an NIH roadmap initiative, PROMIS (Patient-Reported Outcomes Measurement Information System) replaces static legacy questionnaires with large item banks calibrated using Item Response Theory (IRT) (specifically the graded response model). PROMIS measures can be administered as fixed short forms (4, 6, or 8 items) or via Computerized Adaptive Testing (CAT), where an algorithm dynamically selects each subsequent question based on the patient’s previous answer to achieve high measurement precision in 4 to 6 items.
All PROMIS instruments report scores on a standardized T-score metric:
- Mean = 50: Represents the average score of the reference population (typically the U.S. general population).
- Standard Deviation (SD) = 10: Every 10-point increment above or below 50 equals one standard deviation from the reference population mean. In PROMIS, a higher T-score always indicates more of the concept being measured: thus, a T-score of 60 on PROMIS Physical Function indicates function one SD better than average, whereas a T-score of 60 on PROMIS Pain Interference or Fatigue indicates symptom burden one SD worse than average.
Psychometric Validation, MCID, and eCOA / HL7 FHIR Workflows in Clinical Trials
When deploying PROMs in randomized controlled trials—designed in accordance with the SPIRIT-PRO protocol standard and reported under the CONSORT-PRO extension (see CONSORT-PRO and SPIRIT-PRO)—investigators must establish three methodological pillars:
- Psychometric Measurement Properties (COSMIN & FDA Standards): Under the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) taxonomy and FDA COA qualification standards, a PROM must demonstrate content validity (qualitative cognitive interviewing confirming that items and recall periods are relevant and comprehensible to patients in the target context of use), construct validity, reliability (internal consistency via Cronbach’s α and test-retest reliability via the Intraclass Correlation Coefficient [ICC]), and responsiveness to longitudinal clinical change.
- Minimal Clinically Important Difference (MCID) vs. Meaningful Within-Patient Change: Statistical significance in a group-level mean PROM score difference does not automatically prove clinical benefit. Regulators and trialists establish anchor-based thresholds (using an external patient global impression of severity or change scale, PGI-S / PGI-C) to define the Minimal Clinically Important Difference (MCID) or individual responder definition—the minimum score change an individual patient perceives as beneficial and meaningful.
- Electronic Capture (eCOA / ePRO) and HL7 FHIR Mapping: Modern trials and EHR patient portals collect PROMs electronically via web, tablet, or Bring-Your-Own-Device (BYOD) mobile applications with automated timestamps that prevent backfilling (supporting 21 CFR Part 11 and ALCOA+ data integrity). In EHR interoperability workflows governed by the HL7 FHIR Structured Data Capture (SDC) and PRO Implementation Guides, the blank survey instrument is defined as an HL7 FHIR
Questionnaireresource, the patient’s submitted item answers are transmitted as aQuestionnaireResponseresource, and the resulting scored domain or T-score is persisted as a discreteObservationresource coded with LOINC identifiers (for example, LOINC44261-6for the PHQ-9 total score).
Frequently Asked Questions
What are PROMs?
PROMs (Patient-Reported Outcome Measures) are standardized, validated questionnaires completed directly by patients to measure their own perception of their symptoms, functional status, and health-related quality of life without interpretation by a physician or other clinician.
What is the difference between a PRO, a PROM, and a PREM?
A PRO (Patient-Reported Outcome) is the underlying clinical outcome concept reported directly by the patient (such as pain intensity or physical function). A PROM (Patient-Reported Outcome Measure) is the specific validated questionnaire or instrument used to quantify that PRO (such as the PROMIS Physical Function scale or KOOS Jr.). A PREM (Patient-Reported Experience Measure) assesses the patient’s experience of the care delivery process (such as communication and wait times) rather than their clinical health outcome.
How are NIH PROMIS measures scored?
NIH PROMIS instruments use Item Response Theory (IRT) to convert raw item responses into a standardized T-score metric with a mean of 50 and a standard deviation of 10 calibrated to the reference population (typically the U.S. general population). A higher PROMIS T-score always indicates more of the domain being measured—meaning a T-score of 60 represents better function on a function scale or worse symptom severity on a symptom scale.
